UniQuest congratulates Dr David Evans AM on being named a Member in the General Division of the Order of Australia on this year’s Australia Day Honours list.
Dr Evans received the award “for significant service to science and innovation through commercialising and developing new technologies”, many of which originated from University of Queensland (UQ) research.
“We are delighted to see David receive this honour,” said the current UniQuest Managing Director, David Henderson.
“As well as establishing a firm foundation upon which UniQuest has been able to grow into one of Australia’s largest and most successful university research commercialisation companies, David helped to launch many other innovations throughout his career, including the technology based on UQ research which can be found in two-thirds of the world’s MRI machines.
“David mentored many of the commercialisation professionals now leading Australia’s efforts to promote our innovation resources globally, including tech transfer specialists, venture capitalists, intellectual property advisors and researchers.
“It’s an appropriate and well-deserved acknowledgement for someone who has contributed so much in such diverse ways to our industry sector,” Mr Henderson said.
Dr Evans co-founded Uniseed, Australia’s first university-based venture capital fund jointly founded by UQ and the University of Melbourne (with an initial market capitalisation of $20 million), and was its Chief Executive Officer from 2000-2003 after leaving UniQuest. Uniseed continues to support various UniQuest start-ups, including QRxPharma Limited (now listed on the ASX); Spinifex Pharmaceuticals Ltd; TenasiTech Pty Ltd; Q-Sera Pty Ltd; Hydrexia Pty Ltd; ProGel Pty Ltd; and Pepfactants Pty Ltd.
Dr Evans was also a founding director of IMBcom, established to commercialise discoveries from UQ’s Institute for Molecular Bioscience (now under the UniQuest umbrella).
From 2004–2009, Dr Evans was Managing Director and then Executive Chairman of another UniQuest start-up, Magnetica, which is commercialising high-field magnetic resonance technology from UQ’s Centre for Magnetic Resonance.
Prior to Dr Evans’s involvement with research commercialisation at UQ, he was involved with technology and knowledge transfer at the University of New England. He was also known for participating in and contributing to “the mother of all demonstrations” when Doug Engelbart showcased the computer mouse and the “dawn of interactive computing” in 1968.
UniQuest Pty Limited
Established by The University of Queensland in 1984, UniQuest is widely recognised as one of Australia’s largest and most successful university commercialisation groups, benchmarking in the top tier of technology transfer worldwide. From an intellectual property portfolio of 1500+ patents it has created over 70 companies, and since 2000 UniQuest and its start-ups have raised more than A$450 million to take university technologies to market. Annual sales of products using UQ technology and licensed by UniQuest are running at A$3 billion. UniQuest now commercialises innovations developed at The University of Queensland including the Institute for Molecular Bioscience and its commercialisation partner institutions: the University of Wollongong, University of Technology Sydney, James Cook University, University of Tasmania, Mater Medical Research Institute, and Queensland Health. A recent addition to the company is the Queensland Government-supported ilab technology business incubator and accelerator. UniQuest also provides access to an expansive and exclusive network of independent academics to tailor a consulting or project R&D solution to meet the diverse needs of industry and government, facilitating some 500 consulting, expert opinion, testing, and contract research services each year. UniQuest is also a leading Australasian provider of international development assistance recognised for excellence in technical leadership, management and research. Working with agencies such as AusAID, NZAID, the Asian Development Bank and the World Bank, UniQuest has developed and implemented more than 400 projects in 60+ countries throughout the Pacific, South-East Asia, the Indian sub-continent and Africa.
P: +61 7 3365 4037
M: +61 409 767 199